Music and mindfulness in psilocybin therapy for depression
Treatments studied
Part of Mental health clinical trials.
This study tests whether adding music and mindfulness exercises to psilocybin-assisted therapy can help people with moderate to severe depression who haven't gotten better with at least two other antidepressants. It aims to see if this approach can improve mood and well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 or older.
- You have been diagnosed with major depression (moderate to severe) and have not fully responded to at least two different antidepressant treatments during this episode.
- You are currently seeing a psychiatrist regularly.
- You have a friend or family member who can accompany you home after the psilocybin sessions.
- You have been on stable medications for depression for at least 8 weeks, and are willing to keep them the same during the trial.
- You do not have certain medical or psychiatric conditions (like bipolar disorder, psychosis, serious heart problems, or a recent substance use problem).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a single dose of psilocybin can help people with treatment-resistant depression by changing how they focus on themselves. It aims to understand how psilocybin affects brain activity and self-related thinking.
This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.
This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
This study tests whether psilocybin—a psychedelic compound—combined with group therapy can help people with depression. Participants receive guided psilocybin sessions at UCLA and attend group therapy to process the experience.
This study tests whether a psilocybin-based treatment can help people with depression that has not improved after trying several antidepressants. You will receive the study treatment and have brain scans to see how it affects brain connections.
Hear when a new Treatment-Resistant Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.